Cytek Biosciences Statistics
Total Valuation
CTKB has a market cap or net worth of $799.45 million. The enterprise value is $539.19 million.
| Market Cap | 799.45M |
| Enterprise Value | 539.19M |
Important Dates
The last earnings date was Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CTKB has 131.27 million shares outstanding. The number of shares has decreased by -3.37% in one year.
| Shares Outstanding | 131.27M |
| Shares Change (YoY) | -3.37% |
| Shares Change (QoQ) | -1.96% |
| Owned by Insiders (%) | 8.71% |
| Owned by Institutions (%) | 66.41% |
| Float | 106.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 370.37 |
| PS Ratio | 3.98 |
| Forward PS | 3.63 |
| PB Ratio | 2.04 |
| P/FCF Ratio | 536.19 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 361.63 |
Financial Position
The company has a current ratio of 6.99, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.99 |
| Quick Ratio | 5.77 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | 6.82 |
| Interest Coverage | -7.52 |
Financial Efficiency
Return on equity (ROE) is -2.80% and return on invested capital (ROIC) is -6.56%.
| Return on Equity (ROE) | -2.80% |
| Return on Assets (ROA) | -2.30% |
| Return on Capital (ROIC) | -6.56% |
| Revenue Per Employee | $297,021 |
| Profits Per Employee | -$17,027 |
| Employee Count | 676 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.44 |
Taxes
| Income Tax | -4.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.08% in the last 52 weeks. The beta is 1.38, so CTKB's price volatility has been higher than the market average.
| Beta (1Y) | 1.38 |
| 52-Week Price Change | -11.08% |
| 50-Day Moving Average | 6.36 |
| 200-Day Moving Average | 7.03 |
| Relative Strength Index (RSI) | 45.69 |
| Average Volume (30 Days) | 743,967 |
Short Selling Information
The latest short interest is 7.85 million, so 5.98% of the outstanding shares have been sold short.
| Short Interest | 7.85M |
| Short Previous Month | 7.47M |
| Short % of Shares Out | 5.98% |
| Short % of Float | 7.39% |
| Short Ratio (days to cover) | 11.49 |
Income Statement
In the last 12 months, CTKB had revenue of $200.79 million and -$11.51 million in losses. Loss per share was -$0.09.
| Revenue | 200.79M |
| Gross Profit | 111.40M |
| Operating Income | -26.42M |
| Pretax Income | -15.66M |
| Net Income | -11.51M |
| EBITDA | -3.93M |
| EBIT | -13.82M |
| Loss Per Share | -$0.09 |
Balance Sheet
The company has $270.44 million in cash and $10.17 million in debt, giving a net cash position of $260.27 million or $1.98 per share.
| Cash & Cash Equivalents | 270.44M |
| Total Debt | 10.17M |
| Net Cash | 260.27M |
| Net Cash Per Share | $1.98 |
| Equity / Book Value | 392.61M |
| Book Value Per Share | 2.99 |
| Working Capital | 333.08M |
Cash Flow
In the last 12 months, operating cash flow was $6.38 million and capital expenditures -$4.89 million, giving a free cash flow of $1.49 million.
| Operating Cash Flow | 6.38M |
| Capital Expenditures | -4.89M |
| Free Cash Flow | 1.49M |
| FCF Per Share | $0.01 |
Margins
Gross margin is 55.48%, with operating and profit margins of -13.16% and -5.73%.
| Gross Margin | 55.48% |
| Operating Margin | -13.16% |
| Pretax Margin | -7.80% |
| Profit Margin | -5.73% |
| EBITDA Margin | -1.96% |
| EBIT Margin | -6.88% |
| FCF Margin | 0.74% |
Dividends & Yields
CTKB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.37% |
| Shareholder Yield | 3.37% |
| Earnings Yield | -1.44% |
| FCF Yield | 0.19% |
Analyst Forecast
The average price target for CTKB is $8.63, which is 41.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.63 |
| Price Target Difference | 41.48% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTKB has an Altman Z-Score of 5.85 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.85 |
| Piotroski F-Score | 5 |